NIR-II-absorbing diimmonium polymer agent achieves excellent photothermal therapy with induction of tumor immunogenic cell death

J Nanobiotechnology. 2023 Apr 20;21(1):132. doi: 10.1186/s12951-023-01882-7.

Abstract

Photothermal therapy has shown great promise for cancer treatment and second near-infrared (NIR-II) -absorbing particles could further improve its precision and applicability due to its superior penetration depth and new imaging ability. Herein, high NIR-II-absorbing polymer particles were prepared by using soluble isobutyl-substituted diammonium borates (P-IDI). The P-IDI showed stronger absorption at 1000-1100 nm, which exhibited excellent photostability, strong photoacoustic imaging ability and high photothermal conversion efficiency (34.7%). The investigations in vitro and in vivo demonstrated that the excellent photothermal effect facilitated complete tumor ablation and also triggered immunogenic cell death in activation of the immune response. The high solubility and excellent photothermal conversion ability demonstrated that polymer IDI particles were promising theranostic agents for treatment of tumors with minor side effects.

Keywords: Diimmonium salt; NIR-II absorbing organic agent; Photothermal therapy; Tumor immunogenic cell death.

MeSH terms

  • Cell Line, Tumor
  • Humans
  • Immunogenic Cell Death
  • Nanoparticles*
  • Neoplasms* / drug therapy
  • Photoacoustic Techniques* / methods
  • Phototherapy / methods
  • Photothermal Therapy
  • Polymers

Substances

  • Polymers